Planning Capital Management Corp Ironwood Pharmaceuticals Inc Transaction History
Planning Capital Management Corp
- $137 Billion
- Q1 2024
A detailed history of Planning Capital Management Corp transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Planning Capital Management Corp holds 1,303 shares of IRWD stock, worth $8,756. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,303
Previous 253
415.02%
Holding current value
$8,756
Previous $2.9 Million
292.06%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding IRWD
# of Institutions
295Shares Held
170MCall Options Held
27.1MPut Options Held
2.28M-
Black Rock Inc. New York, NY24.2MShares$162 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.5MShares$131 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$110 Million24.97% of portfolio
-
State Street Corp Boston, MA13.9MShares$93.5 Million0.01% of portfolio
-
Pacer Advisors, Inc. Malvern, PA7.21MShares$48.4 Million0.16% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $1.03B
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...